Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Histology and Histopathology

• Publication date

  2020-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14670/HH-18-157PMID 31483053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression

  2018cited by this paper
• Trefoil factor family 1 expression in the invasion front is a poor prognostic factor associated with lymph node metastasis in pancreatic cancer.

  2017cited by this paper
• Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix

  2017cited by this paper
• The role of sex hormones and steroid receptors on female reproductive cancers.

  2017cited by this paper
• Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013

  2017cited by this paper
• The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer

  2017cited by this paper
• Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma

  2016cited by this paper
• Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors

  2016cited by this paper
• Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, -4, -7, occludin and JAM-A, in human cervical adenocarcinoma.

  2016cited by this paper
• Biology and treatment of cervical adenocarcinoma

  2016cited by this paper
• An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens

  2015cited by this paper
• Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma

  2015cited by this paper
• Estrogen biology: new insights into GPER function and clinical opportunities.

  2014cited by this paper
• Adenocarcinoma of the Uterine Cervix: Why Is it Different?

  2014cited by this paper
• Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer

  2014cited by this paper
• New developments in endocervical glandular lesions

  2013cited by this paper
• Expression of estrogen receptors in gastric cancer and their clinical significance

  2012cited by this paper
• Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

  2012cited by this paper
• GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells

  2012cited by this paper
• Epidermal growth factor receptor as a biomarker for cervical cancer.

  2011cited by this paper
• Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro

  2011cited by this paper
• The G-protein-coupled estrogen receptor GPER in health and disease

  2011cited by this paper
• Developments in the systemic treatment of endometrial cancer.

  2011cited by this paper
• Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.

  2010cited by this paper
• G protein-coupled receptor 30 in tumor development

  2010cited by this paper
• Adenocarcinoma: a unique cervical cancer.

  2010cited by this paper
• Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.

  2010cited by this paper
• Mechanisms of estrogen signaling and gene expression via GPR30.

  2009cited by this paper
• GPR30 predicts poor survival for ovarian cancer.

  2009cited by this paper
• GPR30: a novel indicator of poor survival for endometrial carcinoma.

  2007cited by this paper
• Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression

  2006cited by this paper
• The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

  2006cited by this paper
• A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.

  2000cited by this paper
• Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

  2000cited by this paper
• Adenocarcinoma of the cervix

  1997cited by this paper
• Gynaecological monitoring during tamoxifen therapy.

  1994cited by this paper
• Tamoxifen and Endometrial Cancer

  1994cited by this paper
• Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix

  1994cited by this paper
• Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study

  1993cited by this paper

• BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells

  2025cites this paper
• Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis

  2025cites this paper
• Expression of “Hallmarks of Cancer” Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity

  2025cites this paper
• G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity

  2025cites this paper
• The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells

  2024cites this paper
• Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor

  2024cites this paper
• Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells

  2023cites this paper
• Marital status is an independent prognostic factor for cervical adenocarcinoma: A population-based study

  2023cites this paper
• Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells

  2023cites this paper
• Oestrogen receptor-independent actions of oestrogen in cancer

  2023cites this paper
• Aberrant expression of claudin‐6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma

  2022cites this paper
• Proliferation and apoptosis regulation by G protein-coupled estrogen receptor in glioblastoma C6 cells

  2022cites this paper
• Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines

  2022cites this paper
• ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.

  2021cites this paper
• Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression

  2021cites this paper
• The activation of G protein-coupled receptor 30 increases pro-opiomelanocortin gene expression through cAMP/PKA/NR4A pathway in mouse pituitary corticotroph AtT-20 cells.

  2020cites this paper
• Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinoma

  2020cites this paper